• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

herpes simplex virus

Gene therapy shows promising results in eliminating Herpes Simplex Virus infections

Fred Hutchinson Cancer Center, gene therapy, herpes, meganuclease enzyme, 15 May 2024/in E-News /by panglobal

In a groundbreaking study published in Nature Communications [1], researchers at the Fred Hutchinson Cancer Center have reported encouraging findings from pre-clinical studies on an experimental gene therapy for genital and oral herpes infections caused by the herpes simplex virus (HSV).  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/05/herpes1.png 622 799 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-05-15 10:03:142024-05-15 10:03:14Gene therapy shows promising results in eliminating Herpes Simplex Virus infections
dementia

More than 20,000 volunteers join search for new dementia treatment

BioResource, clincal trials, dementia, Genes and Cognition Cohort, NIHR, 14 May 2024/in E-News /by panglobal

More than 20,000 volunteers have enrolled in a resource dedicated to speeding up the development of urgently needed drugs for dementia. This cohort will allow researchers from both academia and industry to involve healthy individuals, potentially at heightened risk of dementia, in clinical trials.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/05/dementia_1.jpg 950 1268 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-05-14 11:05:262024-05-13 11:48:16More than 20,000 volunteers join search for new dementia treatment
C-section birth significantly reduces measles vaccine efficacy in infants

C-section birth significantly reduces measles vaccine efficacy in infants

C-section, immunity, measles, vaccine, 13 May 2024/in E-News /by panglobal

A joint study by researchers from the University of Cambridge and Fudan University has uncovered a significant association between caesarean section (C-section) births and impaired immune response to the first dose of the measles vaccine in infants.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/05/measles.jpg 1354 1352 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-05-13 11:08:082024-05-13 11:08:08C-section birth significantly reduces measles vaccine efficacy in infants
Siemens Healthineers’s new £250m Oxford facility

Siemens Healthineers’s new £250m Oxford facility to be UK’s first major production site for new MRI DryCool technology

DryCool technology, MRI, North Oxfordshire, Siemens Healthineers, 10 May 2024/in E-News /by panglobal

Siemens Healthineers has announced a new £250 million facility in North Oxfordshire that will design and manufacture superconducting magnets for advanced MRI scanners used in healthcare facilities globally. The site will be home to novel technology that minimizes the use of helium, making the MRI scanners lighter, easier to install and more sustainable.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/05/SiemensHealthineers-Oxford_MRI.png 1407 2500 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-05-10 10:28:382024-05-10 10:29:42Siemens Healthineers’s new £250m Oxford facility to be UK’s first major production site for new MRI DryCool technology

Researchers reveal new genetic form of Alzheimer’s disease

, 7 May 2024/in E-News /by panglobal

A study led by researchers from the Dementia Neurobiology Group at the Sant Pau Research Institute, published 6 May 2024 in the journal Nature Medicine, has identified that almost all individuals with two copies of the APOE4 gene develop signs of Alzheimer’s.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/05/Dr-Juan-Fortea.jpg 1124 1380 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-05-07 11:45:032024-05-10 09:23:58Researchers reveal new genetic form of Alzheimer’s disease

Implantable batteries can run on the body’s own oxygen

, 10 April 2024/in E-News /by panglobal

From pacemakers to neurostimulators, implantable medical devices rely on batteries to keep the heart on beat and dampen pain. But batteries eventually run low and require invasive surgeries to replace. To address these challenges, researchers in China devised an implantable battery that runs on oxygen in the body. The study, published March 27 in the […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/04/implantable-battery.png 996 996 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-04-10 13:09:262024-04-10 13:09:26Implantable batteries can run on the body’s own oxygen

Trust your doctor: Study shows human medical professionals are more reliable than ChatGPT-4 and Bard

, 10 April 2024/in E-News /by panglobal

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations and can sometimes generate incorrect advice or instructions. A new study [1] in the American Journal of Preventive Medicine, assesses the accuracy and reliability of […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/04/Scherm­afbeelding-2024-04-10-om-15.02.43.png 1168 2222 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-04-10 13:03:222024-04-10 13:03:22Trust your doctor: Study shows human medical professionals are more reliable than ChatGPT-4 and Bard

eGenesis, PorMedTec produce genetically engineered porcine donors in Japan

, 10 April 2024/in E-News /by panglobal

eGenesis, a biotechnology company developing human-compatible organs and cells for the treatment of organ failure, and PorMedTec, a global leader in porcine embryology, have successfully produced genetically engineered porcine donors in Japan for use in trans­plan­tation.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/04/shutterstock_735346585-scaled.jpg 1280 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-04-10 12:59:142024-04-10 12:59:14eGenesis, PorMedTec produce genetically engineered porcine donors in Japan

Aston University launches SPARK The Midlands to support health tech innovation

, 10 April 2024/in E-News /by panglobal

Aston University has hosted an event to celebrate the launch of SPARK The Midlands www.sparkthemidlands.co.uk, a network which aims to bridge the gap between medical research discoveries of novel therapeutics, medical devices and diagnostics, and real-world clinical use.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/04/shutterstock_1760929442-scaled.jpg 1171 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-04-10 12:03:382024-04-10 12:03:38Aston University launches SPARK The Midlands to support health tech innovation

Collaborative initiative aims to build stronger ties between NHS and industry

, 10 April 2024/in E-News /by panglobal

An initiative with the aim of building stronger relationships between the NHS and industry was recently hosted and organised by the Imperial College Healthcare NHS Trust, in partnership with the Shelford Group and the Association of British HealthTech Industries (ABHI).

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/04/shutterstock_2270669753-scaled.jpg 1709 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-04-10 12:00:522024-04-10 12:00:52Collaborative initiative aims to build stronger ties between NHS and industry
Page 21 of 231«‹1920212223›»

Latest issue of International Hospital

April 2024

27 June 2025

Scientists launch world first project to create synthetic human genome with £10mn Wellcome funding

27 June 2025

GE HealthCare advances precision imaging with MIM Encore platform

27 June 2025

GE HealthCare advances cardiac PET diagnostics with Flyrcado launch

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription